Grupo de Inversiones Suramericana Valuation
Is SURACL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SURACL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SURACL (CLP7898.8) is trading above our estimate of fair value (CLP764.51)
Significantly Below Fair Value: SURACL is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SURACL?
Other financial metrics that can be useful for relative valuation.
| What is SURACL's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | Col$14.46t |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.6x |
| Enterprise Value/EBITDA | 2.5x |
| PEG Ratio | -0.07x |
Price to Earnings Ratio vs Peers
How does SURACL's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 5x | ||
ILC Inversiones La Construcción | 4.1x | n/a | CL$838.9b |
PASUR Forestal Constructora y Comercial del Pacifico Sur | 6.3x | n/a | CL$747.5b |
BICECORP Bicecorp | 6.6x | n/a | CL$1.7t |
MARINSA Marítima de Inversiones | 2.8x | n/a | CL$219.6b |
SURACL Grupo de Inversiones Suramericana | 2.7x | -40.5% | CL$14.5t |
Price-To-Earnings vs Peers: SURACL is good value based on its Price-To-Earnings Ratio (2.7x) compared to the peer average (5x).
Price to Earnings Ratio vs Industry
How does SURACL's PE Ratio compare vs other companies in the South American Diversified Financial Industry?
Price-To-Earnings vs Industry: SURACL is good value based on its Price-To-Earnings Ratio (2.7x) compared to the South American Diversified Financial industry average (7.8x).
Price to Earnings Ratio vs Fair Ratio
What is SURACL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 2.7x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SURACL's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CL$7,898.80 | CL$7,651.12 -3.1% | 21.4% | CL$9,893.69 | CL$6,029.33 | n/a | 3 |
| May ’25 | CL$7,898.80 | CL$7,209.77 -8.7% | 18.4% | CL$9,243.29 | CL$5,632.97 | n/a | 4 |
| Apr ’25 | CL$7,898.80 | CL$7,209.77 -8.7% | 18.4% | CL$9,243.29 | CL$5,632.97 | n/a | 4 |
| Mar ’25 | CL$7,898.80 | CL$7,209.77 -8.7% | 18.4% | CL$9,243.29 | CL$5,632.97 | n/a | 4 |
| Feb ’25 | CL$7,898.80 | CL$7,209.77 -8.7% | 18.4% | CL$9,243.29 | CL$5,632.97 | n/a | 4 |
| Jan ’25 | CL$7,898.80 | CL$7,209.77 -8.7% | 18.4% | CL$9,243.29 | CL$5,632.97 | n/a | 4 |
| Dec ’24 | CL$7,898.80 | CL$7,209.77 -8.7% | 18.4% | CL$9,243.29 | CL$5,632.97 | n/a | 4 |
| Nov ’24 | CL$7,898.80 | CL$7,003.05 -11.3% | 14.0% | CL$7,941.15 | CL$5,650.43 | n/a | 3 |
| Oct ’24 | CL$7,898.80 | CL$7,133.27 -9.7% | 12.1% | CL$8,063.70 | CL$5,737.63 | n/a | 4 |
| Sep ’24 | CL$7,898.80 | CL$6,096.99 -22.8% | 13.7% | CL$7,023.12 | CL$4,997.22 | n/a | 3 |
| Aug ’24 | CL$7,898.80 | CL$6,096.99 -22.8% | 13.7% | CL$7,023.12 | CL$4,997.22 | n/a | 3 |
| Jul ’24 | CL$7,898.80 | CL$5,118.97 -35.2% | 13.6% | CL$6,094.21 | CL$4,336.26 | n/a | 4 |
| Jun ’24 | CL$7,898.80 | CL$5,118.97 -35.2% | 13.6% | CL$6,094.21 | CL$4,336.26 | CL$7,898.80 | 4 |
| May ’24 | CL$7,898.80 | CL$5,118.97 -35.2% | 13.6% | CL$6,094.21 | CL$4,336.26 | CL$7,898.80 | 4 |
| Apr ’24 | CL$7,898.80 | CL$5,118.97 -35.2% | 13.6% | CL$6,094.21 | CL$4,336.26 | CL$7,898.80 | 4 |
| Mar ’24 | CL$7,898.80 | CL$5,118.97 -35.2% | 13.6% | CL$6,094.21 | CL$4,336.26 | CL$7,898.80 | 4 |
| Feb ’24 | CL$7,898.80 | CL$5,593.95 -29.2% | 13.6% | CL$6,659.68 | CL$4,738.62 | CL$7,898.80 | 4 |
| Jan ’24 | CL$7,898.80 | CL$5,593.95 -29.2% | 13.6% | CL$6,659.68 | CL$4,738.62 | CL$7,898.80 | 4 |
| Dec ’23 | CL$7,898.80 | CL$5,593.95 -29.2% | 13.6% | CL$6,659.68 | CL$4,738.62 | CL$7,898.80 | 4 |
| Nov ’23 | CL$7,898.80 | CL$6,098.59 -22.8% | 13.6% | CL$7,486.97 | CL$5,327.27 | CL$7,898.80 | 4 |
| Oct ’23 | CL$8,651.30 | CL$5,938.96 -31.4% | 8.6% | CL$6,745.99 | CL$5,359.55 | CL$7,898.80 | 4 |
| Sep ’23 | CL$7,874.00 | CL$5,938.96 -24.6% | 8.6% | CL$6,745.99 | CL$5,359.55 | CL$7,898.80 | 4 |
| Aug ’23 | CL$9,370.70 | CL$6,339.43 -32.3% | 8.2% | CL$7,153.32 | CL$5,735.94 | CL$7,898.80 | 4 |
| Jul ’23 | CL$9,472.50 | CL$6,339.43 -33.1% | 8.2% | CL$7,153.32 | CL$5,735.94 | CL$7,898.80 | 4 |
| Jun ’23 | CL$7,571.10 | CL$6,055.23 -20.0% | 8.2% | CL$6,832.62 | CL$5,478.79 | CL$7,898.80 | 4 |
Analyst Forecast: Target price is lower than the current share price.